05Oct
03Oct
Platelet Biogenesis and Scaled Biolabs to Collaborate to Optimize Platelet Production Platform
Platelet BioGenesis (PBG), the leader in the production of functional human platelets (PLTs+™) from stem cells and the development of platelet-based therapeutics, and Scaled Biolabs (Scaled) announced the two firms are collaborating to optimize PBG’s unique production process for making human platelets, or PLTs+™. The agreement was announced at the SynBioBeta 2018 biology summit. Read more >>
02Oct
Western New York Impact Investing Fund backs recycled insulation startup Cleanfiber
The Western New York Impact Investment Fund has backed Cleanfiber to add a new production facility and create dozens of jobs in… Western New York. Read more >>
02Oct
43North winner raises $4.9 million to advance plans for local factory
CleanFiber has raised $4.9 million in private financing as it enacts plans to open a full-fledged factory in Western New York in the next few months. Read more >>
27Sep
Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in October
Corbus Pharmaceuticals Holdings, Inc., a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases by leveraging its industry leading pipeline of endocannabinoid system-targeting drug candidates, announced today that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will present at two upcoming investor conferences in October. Read more >>
25Sep
Pixability Expands Overseas And Into Advanced Television
Pixability has built its business providing video advertising software across the walled gardens of the biggest social media platforms. Now it’s eying the over-the-top and connected-TV space as well, armed with a new offering that automates data analysis around video creative. Read more >>
20Sep
Respiratory Motion, Inc. Awarded National Group Breakthrough Technologies Purchasing Contract by Premier
Respiratory Motion, Inc. is announcing the award of a group purchasing agreement as a Breakthrough Technology with Premier Inc., a leading healthcare improvement company. Read more >>
19Sep
Myomo to Present at The MicroCap Conference
Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it will be presenting at The MicroCap Conference on Monday, October 1st at 11:00 AM EDT, Track 1, Essex House in New York City. Read more >>
19Sep
Corbus Pharmaceuticals receives Orphan Designation for lenabasum for the treatment of DM in EU
Corbus Pharmaceuticals announces that the European Commission has granted Orphan Designation in the European Union (EU) to lenabasum, its synthetic oral endocannabinoid-mimetic drug, for the treatment of dermatomyositis (DM). Read more >>
15Sep